FOLD
Featured PickAmicus Therapeutics, Inc.
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
85
Entry Price
$14.37
Current Price
$37.69
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-03-11
Executive Summary
Amicus Therapeutics (FOLD) presents a compelling idiosyncratic opportunity insulated from current geopolitical macro risks, driven by its pending $4.8 billion all-cash acquisition by BioMarin at $14.50 per share. With shareholders overwhelmingly approving the merger earlier this month, the stock is experiencing intense upside pressure as a classic Squeeze Play. This setup perfectly aligns with the current CAUTION regime's flight-to-quality, offering an anchored valuation that ignores the broader market's Middle East volatility.
Technical Context
Setup
The stock is pressing directly against its 52-week high (just -0.1% away) with a market-leading confluence score of 16.0 and strong volume confirmation at 1.4x its 20-day average.
Invalidation (Stop)
The bullish thesis is invalidated if shares break below the hard support level of $14.30, which would signal an unexpected breakdown in the merger arbitrage spread.
Runner-ups
Recent Performance History
26 Total Picks • 57% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-03-10 | ALEX | $20.83 | $20.83 | +0.00% | N/A | N/A | N/A |
| 2026-03-09 | EMD | $10.36 | $10.50 | +1.35% | N/A | N/A | N/A |
| 2026-03-06 | DHIL | $172.54 | $173.19 | +0.38% | N/A | N/A | N/A |
| 2026-03-05 | FOLD | $14.33 | $14.37 | +0.28% | N/A | N/A | N/A |
| 2026-02-24 | AES | $16.27 | $14.23 | -12.54% | -12.60% | N/A | N/A |
| 2026-02-23 | PRA | $24.40 | $24.53 | +0.53% | +0.98% | N/A | N/A |
| 2026-02-20 | ST | $38.35 | $35.38 | -7.74% | -10.72% | N/A | N/A |
| 2026-02-19 | FTI | $61.76 | $64.38 | +4.24% | +4.34% | N/A | N/A |
| 2026-02-18 | FOLD | $14.34 | $14.37 | +0.21% | -0.07% | N/A | N/A |
| 2026-02-17 | ROL | $60.08 | $56.08 | -6.66% | +0.72% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0